Good Morning Gumnut,
Would you mind casting your eye over the press release from a French pharma Erytech. They have released their phase 3 results which have fallen to some extent to reach end points.
I'm interested in the references to the chemo drugs gemcirabine and ironotecan and how this outcome may benefit SPL and spotlight the DEP platform.
I'm without a computer this week as I'm off site...so hard to read on phone.
Thank you in advance
DEP phase 2 trials - patience required!, page-10
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |